Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
When life is difficult, small things make a big difference, columnist Kristin Neva writes. She and her husband, Todd, are still learning.
Clene will have an in-person meeting with the FDA before the end of November to discuss a potential CNM-Au8 accelerated ...
A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...